Market Scorecard
Market Pathways Scorecard: FDA Trends Edition
A graphic look at Q1 2024 approvals and review status.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
The Brief
Conformal Medical Begins Pivotal LAAO Trial
Left atrial appendage closure is a well-validated treatment to prevent stroke in AFib patients, but current device options do not allow physicians to streamline their practices to their needs. Conformal Medical’s CLAAS device, now in a large, randomized pivotal trial, was created to address a market ripe with growth while supporting greater case volumes and safer outcomes.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Pathways’ Pick of the Week
Pathways' Pick of the Week: CMS Seeks Diabetes Device Endpoints Guidance
CMS aims to identify diabetes endpoints. Excerpted from Pathways' Picks March 27: Dx Debate, Medicare Diabetes Endpoints, EU Expert Panels, and Global Picks.